- Home
- LVLU vs FBIO Comparison
LVLU vs FBIO Comparison
Compare LVLU & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- FBIO
- Stock Information
- Founded
- LVLU 1996
- FBIO 2006
- Country
- LVLU United States
- FBIO United States
- Employees
- LVLU N/A
- FBIO N/A
- Industry
- LVLU Catalog/Specialty Distribution
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LVLU Consumer Discretionary
- FBIO Health Care
- Exchange
- LVLU Nasdaq
- FBIO Nasdaq
- Market Cap
- LVLU 47.5M
- FBIO 39.4M
- IPO Year
- LVLU 2021
- FBIO N/A
- Fundamental
- Price
- LVLU $0.94
- FBIO $1.84
- Analyst Decision
- LVLU Hold
- FBIO Strong Buy
- Analyst Count
- LVLU 3
- FBIO 3
- Target Price
- LVLU $1.58
- FBIO $18.00
- AVG Volume (30 Days)
- LVLU 30.8K
- FBIO 405.3K
- Earning Date
- LVLU 03-05-2025
- FBIO 03-27-2025
- Dividend Yield
- LVLU N/A
- FBIO N/A
- EPS Growth
- LVLU N/A
- FBIO N/A
- EPS
- LVLU N/A
- FBIO N/A
- Revenue
- LVLU $324,699,000.00
- FBIO $81,501,000.00
- Revenue This Year
- LVLU N/A
- FBIO N/A
- Revenue Next Year
- LVLU $1.72
- FBIO $128.63
- P/E Ratio
- LVLU N/A
- FBIO N/A
- Revenue Growth
- LVLU N/A
- FBIO 31.51
- 52 Week Low
- LVLU $0.81
- FBIO $1.36
- 52 Week High
- LVLU $2.13
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- LVLU 32.48
- FBIO 45.28
- Support Level
- LVLU $0.82
- FBIO $1.71
- Resistance Level
- LVLU $0.93
- FBIO $1.85
- Average True Range (ATR)
- LVLU 0.07
- FBIO 0.09
- MACD
- LVLU -0.00
- FBIO -0.01
- Stochastic Oscillator
- LVLU 16.60
- FBIO 44.23
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.